Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE: 688506)
Health Care · Pharmaceuticals · CN
CN¥282.71
-6.39% today · -14.3% 1Y
Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE: 688506) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $17.36B.
Over the last twelve months the share price has lost 14.3%, trading between 200.10 and 414.02.
Tweenvest scores Sichuan Biokin Pharmaceutical Co.,Ltd. across four factors: quality 43/100, value 59/100, growth 0/100. Its strongest factor is value.
688506 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.36B
- Revenue (TTM)
- $369.31M
- P/E
- —
- EPS
- -3.19
- Dividend yield
- —
- Beta (5Y)
- -0.05
- 52-week high
- CN¥414.02
- 52-week low
- CN¥200.10
- Avg volume (3M)
- —
- Shares outstanding
- 412.87M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.